Search research articles
Contact Us
Filters
Showing results (31-40 of 119) with videos related to
Page
of 12
Sort By:
Oncology
|
October 6, 2017
Retrospective Analysis of CA19-9 Decrease in Patients with Metastatic Pancreatic Carcinoma Treated with FOLFIRINOX or Gemcitabine in a Randomized Phase III Study (ACCORD11/PRODIGE4)
Marie Robert, Marta Jarlier, Sophie Gourgou, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
July 15, 2017
Psychometric evaluation of an item bank for computerized adaptive testing of the EORTC QLQ-C30 cognitive functioning dimension in cancer patients
Linda Dirven, Mogens Groenvold, Martin J B Taphoorn, et al.
Cancers
|
October 27, 2022
Development of a Clinical-Biological Model to Assess Tumor Progression in Metastatic Pancreatic Cancer: Post Hoc Analysis of the PRODIGE4/ACCORD11 Trial
Julie Egea, Julia Salleron, Sophie Gourgou, et al.
Irish Journal of Medical Science
|
December 23, 2023
The role of total neoadjuvant therapy in locally advanced rectal cancer: a survey of specialists attending the All-Ireland Colorectal Cancer Conference 2022 including lead investigators of OPRA, PRODIGE-23 and RAPIDO
Timothy O'Brien, Geke Hospers, Thierry Conroy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 7, 2005
Use of a decision analysis model to assess the cost-effectiveness of 18F-FDG PET in the management of metachronous liver metastases of colorectal cancer
Catherine Lejeune, Marie J Bismuth, Thierry Conroy, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 22, 2005
Combined radiotherapy, 5-fluorouracil continuous infusion and weekly oxaliplatin in advanced rectal cancer: a phase I study
Eric François, Marc Ychou, Michel Ducreux, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 17, 2023
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER PRODIGE 23): Health-related quality of life longitudinal analysis
Caroline Bascoul-Mollevi, Sophie Gourgou, Christophe Borg, et al.
Cancers
|
March 12, 2020
Primary Thromboprophylaxis in Pancreatic Cancer Patients: Why Clinical Practice Guidelines Should Be Implemented
Dominique Farge, Barbara Bournet, Thierry Conroy, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 7, 2016
Current standards and new innovative approaches for treatment of pancreatic cancer
Thierry Conroy, Jean-Baptiste Bachet, Ahmet Ayav, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 22, 2005
Does a patient's self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer?
Fabio Efficace, Andrew Bottomley, Corneel Coens, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 119) with videos related to
Sort By:
Page
of 12
Oncology
|
October 6, 2017
Retrospective Analysis of CA19-9 Decrease in Patients with Metastatic Pancreatic Carcinoma Treated with FOLFIRINOX or Gemcitabine in a Randomized Phase III Study (ACCORD11/PRODIGE4)
Marie Robert, Marta Jarlier, Sophie Gourgou, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
July 15, 2017
Psychometric evaluation of an item bank for computerized adaptive testing of the EORTC QLQ-C30 cognitive functioning dimension in cancer patients
Linda Dirven, Mogens Groenvold, Martin J B Taphoorn, et al.
Cancers
|
October 27, 2022
Development of a Clinical-Biological Model to Assess Tumor Progression in Metastatic Pancreatic Cancer: Post Hoc Analysis of the PRODIGE4/ACCORD11 Trial
Julie Egea, Julia Salleron, Sophie Gourgou, et al.
Irish Journal of Medical Science
|
December 23, 2023
The role of total neoadjuvant therapy in locally advanced rectal cancer: a survey of specialists attending the All-Ireland Colorectal Cancer Conference 2022 including lead investigators of OPRA, PRODIGE-23 and RAPIDO
Timothy O'Brien, Geke Hospers, Thierry Conroy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 7, 2005
Use of a decision analysis model to assess the cost-effectiveness of 18F-FDG PET in the management of metachronous liver metastases of colorectal cancer
Catherine Lejeune, Marie J Bismuth, Thierry Conroy, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 22, 2005
Combined radiotherapy, 5-fluorouracil continuous infusion and weekly oxaliplatin in advanced rectal cancer: a phase I study
Eric François, Marc Ychou, Michel Ducreux, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 17, 2023
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER PRODIGE 23): Health-related quality of life longitudinal analysis
Caroline Bascoul-Mollevi, Sophie Gourgou, Christophe Borg, et al.
Cancers
|
March 12, 2020
Primary Thromboprophylaxis in Pancreatic Cancer Patients: Why Clinical Practice Guidelines Should Be Implemented
Dominique Farge, Barbara Bournet, Thierry Conroy, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 7, 2016
Current standards and new innovative approaches for treatment of pancreatic cancer
Thierry Conroy, Jean-Baptiste Bachet, Ahmet Ayav, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 22, 2005
Does a patient's self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer?
Fabio Efficace, Andrew Bottomley, Corneel Coens, et al.
Page
of 12